T. Blakely et al., HEPATITIS-B VIRUS CARRIER PREVALENCE IN NEW-ZEALAND - POPULATION ESTIMATES USING THE 1987 POLICE AND CUSTOMS PERSONNEL SURVEY, New Zealand medical journal, 111(1064), 1998, pp. 143-144
Aim. To estimate the population hepatitis B surface antigen (HBsAg) ca
rrier prevalence for adults in New Zealand. Method. Data for 1987 from
the New Zealand Police Department and New Zealand Customs Department
hepatitis B sere-marker survey were further analysed. The sample size
was 5510 staff who had completed a questionnaire, had blood sera taken
and were not already immunised against hepatitis B. Results. Maori ad
ults had a HBsAg carrier prevalence of 5.43% (95% confidence interval
3.07-8.81), Pacific adults 4.44% (1.65-9.42), and European adults 0.42
% (0.26-0.65). Other ethnic minorities and people with two or more sel
f-assigned ethnic identities had a carrier prevalence of 3.85% (1.06-9
.56). There were non-significant differences in this study for carrier
prevalence by sex, age and region. Conclusions. Policy formation on s
creening programmes for hepatitis B carriers should assume a HBSAg car
rier prevalence of about 5% for Maori, Pacific people and ethnic minor
ities, and about 0.5% for New Zealanders of European extraction.